Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 4245028, 9 pages
http://dx.doi.org/10.1155/2016/4245028
Research Article

A Mutation in IL4RA Is Associated with the Degree of Pathology in Human TB Patients

1Infection Immunology, Research Center Borstel, Parkallee 22, 23845 Borstel, Germany
2German Center for Infection Research, Germany
3Department of Community Health, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
4Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, 20359 Hamburg, Germany
5Microbial Inflammation Research, Research Center Borstel, Parkallee 22, 23845 Borstel, Germany
6Molecular Inflammation Medicine, Christian Albrechts University, Christian-Albrechts-Platz 4, 24098 Kiel, Germany

Received 21 October 2015; Accepted 12 January 2016

Academic Editor: Shen-An Hwang

Copyright © 2016 Christoph Hölscher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Global Tuberculosis Report—2015, edited by: WHO, World Health Organization, Geneva, Switzerland, 2015.
  2. S. Ehlers and C. Hölscher, “DTH-associated pathology,” in Microbiology and Microbial Infections, S. H. Kaufmann, Ed., pp. 705–720, Arnold Publsihing, London, UK, 2005. View at Google Scholar
  3. G. A. W. Rook, “Th2 cytokines in susceptibility to tuberculosis,” Current Molecular Medicine, vol. 7, no. 3, pp. 327–337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. G. T. Seah, G. M. Scott, and G. A. W. Rook, “Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis,” Journal of Infectious Diseases, vol. 181, no. 1, pp. 385–389, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Mazzarella, A. Bianco, F. Perna et al., “T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis,” Clinical and Experimental Immunology, vol. 132, no. 2, pp. 283–288, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. R. van Crevel, E. Karyadi, F. Preyers et al., “Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities,” Journal of Infectious Diseases, vol. 181, no. 3, pp. 1194–1197, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Heitmann, M. A. Dar, T. Schreiber et al., “The IL-13/IL-4Rα axis is involved in tuberculosis-associated pathology,” Journal of Pathology, vol. 234, no. 3, pp. 338–350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Thye, E. N. Browne, M. A. Chinbuah et al., “No associations of human pulmonary tuberculosis with Sp110 variants,” Journal of Medical Genetics, vol. 43, no. 7, article e32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. L. J. Rosenwasser, D. J. Klemm, J. K. Dresback et al., “Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy,” Clinical and Experimental Allergy, vol. 25, supplement 2, pp. 74–78, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. T. C. T. M. van der Pouw Kraan, A. van Veen, L. C. M. Boeije et al., “An IL-13 promoter polymorphism associated with increased risk of allergic asthma,” Genes and Immunity, vol. 1, no. 1, pp. 61–65, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Mitsuyasu, K. Izuhara, X. Q. Mao et al., “Ile50Val variant of IL4R α upregulates IgE synthesis and associates with atopic asthma,” Nature Genetics, vol. 19, no. 2, pp. 119–120, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Heinzmann, X.-Q. Mao, M. Akaiwa et al., “Genetic variants of IL-13 signalling and human asthma and atopy,” Human Molecular Genetics, vol. 9, no. 4, pp. 549–559, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Granel, Y. Allanore, C. Chevillard et al., “IL13RA2 gene polymorphisms are associated with systemic sclerosis,” The Journal of Rheumatology, vol. 33, no. 10, pp. 2015–2019, 2006. View at Google Scholar · View at Scopus
  14. D. R. Herbert, C. Hölscher, M. Mohrs et al., “Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology,” Immunity, vol. 20, no. 5, pp. 623–635, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Schreiber, S. Ehlers, L. Heitmann et al., “Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity,” The Journal of Immunology, vol. 183, no. 2, pp. 1301–1312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Hölscher, N. Reiling, U. E. Schaible et al., “Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9,” European Journal of Immunology, vol. 38, no. 3, pp. 680–694, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Dheda, J. S. Chang, R. A. Breen et al., “In vivo and in vitro studies of a novel cytokine, interleukin 4δ2, in pulmonary tuberculosis,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 4, pp. 501–508, 2005. View at Publisher · View at Google Scholar
  18. M. C. Jiménez-Martínez, M. Linares, R. Báez et al., “Intracellular expression of interleukin-4 and interferon-γ by a Mycobacterium tuberculosis antigen-stimulated CD4+ CD57+ T-cell subpopulation with memory phenotype in tuberculosis patients,” Immunology, vol. 111, no. 1, pp. 100–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Dlugovitzky, O. Bottasso, J. C. Dominino et al., “Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172),” Respiratory Medicine, vol. 93, no. 8, pp. 557–562, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. F. O. Sanchez, J. I. Rodriguez, G. Agudelo, and L. F. Garcia, “Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls,” Infection and Immunity, vol. 62, no. 12, pp. 5673–5678, 1994. View at Google Scholar · View at Scopus
  21. S. M. Smith, M. R. Klein, A. S. Malin, J. Sillah, K. P. W. J. McAdam, and H. M. Dockrell, “Decreased IFN-γ and increased IL-4 production by human CD8+ T cells in response to Mycobacterium tuberculosis in tuberculosis patients,” Tuberculosis, vol. 82, no. 1, pp. 7–13, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. S. K. Sharma, D. K. Mitra, A. Balamurugan, R. M. Pandey, and N. K. Mehra, “Cytokine polarization in miliary and pleural tuberculosis,” Journal of Clinical Immunology, vol. 22, no. 6, pp. 345–352, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Marchant, A. Amedei, A. Azzurri et al., “Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-α or interleukin-12,” American Journal of Respiratory Cell and Molecular Biology, vol. 24, no. 2, pp. 187–194, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Lienhardt, A. Azzurri, A. Amedei et al., “Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo,” European Journal of Immunology, vol. 32, no. 6, pp. 1605–1613, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Fenhalls, A. Wong, J. Bezuidenhout, P. van Helden, P. Bardin, and P. T. Lukey, “In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas,” Infection and Immunity, vol. 68, no. 5, pp. 2827–2836, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Fichtner-Feigl, W. Strober, K. Kawakami, R. K. Puri, and A. Kitani, “IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis,” Nature Medicine, vol. 12, no. 1, pp. 99–106, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. G. Chiaramonte, D. D. Donaldson, A. W. Cheever, and T. A. Wynn, “An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response,” The Journal of Clinical Investigation, vol. 104, no. 6, pp. 777–785, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Wood, M. J. Whitters, B. A. Jacobson et al., “Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor α 2,” Journal of Experimental Medicine, vol. 197, no. 6, pp. 703–709, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Guler, S. P. Parihar, S. Savvi et al., “IL-4Ralpha-dependent alternative activation of macrophages is not decisive for Mycobacterium tuberculosis pathology and bacterial burden in mice,” PLoS ONE, vol. 10, no. 3, Article ID e0121070, 2015. View at Publisher · View at Google Scholar
  30. K. C. El Kasmi, J. E. Qualls, J. T. Pesce et al., “Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens,” Nature Immunology, vol. 9, no. 12, pp. 1399–1406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Hesse, M. Modolell, A. C. La Flamme et al., “Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism,” The Journal of Immunology, vol. 167, no. 11, pp. 6533–6544, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. A. H. Zea, K. S. Culotta, J. Ali et al., “Decreased expression of CD3ζ and nuclear transcription factor κB in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment,” Journal of Infectious Diseases, vol. 194, no. 10, pp. 1385–1393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Monin, K. L. Griffiths, W. Y. Lam et al., “Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis,” Journal of Clinical Investigation, vol. 125, no. 12, pp. 4699–4713, 2015. View at Publisher · View at Google Scholar
  34. L. C. Borish, H. S. Nelson, M. J. Lanz et al., “Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 1816–1823, 1999. View at Publisher · View at Google Scholar · View at Scopus